134 related articles for article (PubMed ID: 34759149)
1. Plasma Cystatin C Level is a Prognostic Marker of Morbidity and Mortality in Hospitalized Decompensated Cirrhotic Patients.
Aumpan N; Limprukkasem T; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Tantiyavarong P; Siramolpiwat S
J Med Invest; 2021; 68(3.4):302-308. PubMed ID: 34759149
[TBL] [Abstract][Full Text] [Related]
2. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.
Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL
Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.
Wan ZH; Wang JJ; You SL; Liu HL; Zhu B; Zang H; Li C; Chen J; Xin SJ
World J Gastroenterol; 2013 Dec; 19(48):9432-8. PubMed ID: 24409073
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding.
Hong C; Zhu Q; Li Y; Tang S; Lin S; Yang Y; Yuan S; Shao L; Wu Y; Liu B; Li B; Meng F; Chen Y; Hong M; Qi X
Ren Fail; 2022 Dec; 44(1):398-406. PubMed ID: 35225149
[TBL] [Abstract][Full Text] [Related]
5. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
[TBL] [Abstract][Full Text] [Related]
6. Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study.
Kim TH; Seo YS; Kang SH; Kim MY; Kim SG; Lee HY; Lee JH; Lee YS; Kim JH; Jeong SW; Jang JY; Suk KT; Jung YK; An H; Yim HJ; Kim YS; Um SH;
Liver Int; 2020 Dec; 40(12):3083-3092. PubMed ID: 32750739
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
[TBL] [Abstract][Full Text] [Related]
8. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.
Jo SK; Yang J; Hwang SM; Lee MS; Park SH
Sci Rep; 2019 Oct; 9(1):14508. PubMed ID: 31601879
[TBL] [Abstract][Full Text] [Related]
9. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
[TBL] [Abstract][Full Text] [Related]
10. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
Seo YS; Jung ES; An H; Kim JH; Jung YK; Kim JH; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
[TBL] [Abstract][Full Text] [Related]
11. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
Jha P; Jha AK; Dayal VM; Jha SK; Kumar A
Indian J Gastroenterol; 2021 Dec; 40(6):563-571. PubMed ID: 34981441
[TBL] [Abstract][Full Text] [Related]
12. Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.
Treeprasertsuk S; Wongkarnjana A; Jaruvongvanich V; Sallapant S; Tiranathanagul K; Komolmit P; Tangkijvanich P
BMC Gastroenterol; 2015 Oct; 15():140. PubMed ID: 26474856
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
Jiang QQ; Han MF; Ma K; Chen G; Wan XY; Kilonzo SB; Wu WY; Wang YL; You J; Ning Q
World J Gastroenterol; 2018 Jun; 24(21):2300-2310. PubMed ID: 29881239
[TBL] [Abstract][Full Text] [Related]
14. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure.
Lu J; Lin L; Ye C; Tao Q; Cui M; Zheng S; Zhu D; Liu L; Xue Y
Ann Hepatol; 2019; 18(1):155-164. PubMed ID: 31113585
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
[TBL] [Abstract][Full Text] [Related]
16. Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS.
Torner M; Mangal A; Scharnagl H; Jansen C; Praktiknjo M; Queck A; Gu W; Schierwagen R; Lehmann J; Uschner FE; Graf C; Strassburg CP; Fernandez J; Stojakovic T; Woitas R; Trebicka J
Liver Int; 2020 Jan; 40(1):186-193. PubMed ID: 31448496
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates.
Hidayati EL; Utami MD; Rohsiswatmo R; Tridjaja B
Pediatr Nephrol; 2021 Jan; 36(1):181-186. PubMed ID: 32594242
[TBL] [Abstract][Full Text] [Related]
18. Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis.
Wu J; Wu Q; Wu M; Mao W
Biomed Res Int; 2019; 2019():7272045. PubMed ID: 30949507
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study.
Maiwall R; Kumar A; Bhardwaj A; Kumar G; Bhadoria AS; Sarin SK
Liver Int; 2018 Apr; 38(4):654-664. PubMed ID: 28941301
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.
Kim DJ; Kang HS; Choi HS; Cho HJ; Kim ES; Keum B; An H; Kim JH; Seo YS; Kim YS; Yim HJ; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
Korean J Hepatol; 2011 Jun; 17(2):130-8. PubMed ID: 21757984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
